Instrument Inactif

Communiqués ZIVO Bioscience, Inc. Other OTC

Actions

ZIVO

US98978N1019

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ZIVO BIOS : Quarterly Results (Excel)	13/05	PU
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	07/02	BU
ZIVO Bioscience Announces Uplisting to OTCQB Market	29/01	BU
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	30/10/23	BU
ZIVO Bioscience Announces Reverse Stock Split	26/10/23	BU
ZIVO Bioscience : Dawon James Small Cap Growth Conference Presentation	12/10/23	PU
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference	03/10/23	GL
Trial Results Confirm Efficacy of ZIVO Bioscience's Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	20/09/23	AQ
Trial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	19/09/23	BU
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife Algal Biomass Product Produced Over the Next 18 Months	17/08/23	AQ
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 Months	16/08/23	BU
ZIVO Commences Sales of its Proprietary Algal Biomass as Human Food	26/07/23	BU
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market	03/07/23	AQ
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market	30/06/23	BU
ZIVO Bioscience : Submission of Matters to a Vote of Security Holders - Form 8-K	16/06/23	PU
ZIVO's GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient	31/05/23	AQ
ZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient	30/05/23	BU
ZIVO Bioscience : Failure to Satisfy Listing Rule - Form 8-K	27/05/23	PU
ZIVO BIOSCIENCE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	05/04/23	AQ
ZIVO Bioscience Receives $1 Million Bridge Financing	05/04/23	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués ZIVO Bioscience, Inc. Other OTC

Actions

ZIVO

US98978N1019

Communiqués

Filtres